
Get started
Sign in
Close

Device evidence, reimagined

Research-ready data with unmatched precision and traceability

Request a feasibility
Thank you for your interest!
Close

Device-level data from EHRs, claims, and chargemaster

Truveta delivers complete, representative, and trusted EHR data—spanning more than 120 million patients and 45 million devices—with granular device-level insights and minute-level timestamps. Cleaned with AI and linked to claims and chargemaster, this single dataset covers the entire patient journey.

Breadth and depth with full traceability

Traditional, standalone data sources—claims, chargemaster, and registries—were never built for lifecycle-wide evidence. They provide fragments of the picture but, alone, cannot deliver the precision, speed, or representativeness regulators and payers now expect.

Truveta’s governing health systems contribute de-identified EHR and chargemaster data directly, delivering unmatched clinical depth with full provenance back to source. Linked claims extend that insight, providing cost and utilization data to power robust economic analyses with clinical context.

Explore Truveta Data

130M+

patients

45M+

unique devices

10+

years longitudinal data

4B+

devices + claims

5M+

devices + imaging

10M+

devices + clinical notes
Explore Truveta Data
{
“Truveta Data gave us the granularity we needed to move beyond broad comparisons and start evaluating the safety and efficacy of individual design variations; insights that were previously out of reach.”

George Miller

Director of Clinical Affairs, Medcomp

Purpose-built for device evidence

Get the details needed to study utilization, safety, effectiveness, and cost with confidence. 

Device-level granularity

Device-level granularity

Identifies each device down to manufacturer, model, lot, and expiration, enabling traceability and comparative analyses

Admission–Discharge–Transfer (ADT) data

Admission–Discharge–Transfer (ADT) data

Captures minute-level patient flow to study surgical efficiency, ICU transfers, recovery timelines, and discharge outcomes

Procedure log data

Procedure log data

Reconstructs surgeries and interventions step by step, linking devices to pre- and post-procedure context

Linked chargemaster

Linked chargemaster

Connects utilization and cost data to clinical encounters, supporting reliable economic and outcomes research

Clinical notes

Clinical notes

Capture nuanced outcomes and context with more than 10 million notes tied to patients with device records

Imaging at scale

Imaging at scale

Confirm device placement and monitor outcomes with more than 5 million images tied to patients with device records
Read our medical device whitepaper

Evidence across the lifecycle, in any therapeutic area

Across cardiovascular, orthopedics, neurology, and more, Truveta accelerates adoption and reduces risk from product development through real-world use.

De-risk trials with real-world feasibility modeling, real-time site- and provider-level visibility, and partnership opportunities with leading US health systems.

Demonstrate value faster to payers and providers by linking device use to utilization, outcomes, and costs.

Expand total addressable market by uncovering disparities in access and adoption.

Support regulatory submissions and post-approval commitments with fully traceable, auditable real-world data.

Monitor safety signals during and after studies with daily refreshed data spanning care settings.

Case studies

Boston Scientific

Comparing real-world outcomes

Evidence of lower bleeding risk vs. competitor device built confidence and accelerated adoption.

5 Read the case study

Reprieve Cardiovascular

De-risking trial design

Dataset 3x larger than legacy registry used to refine eligibility criteria and confirm trial feasibility.

5 Read the case study

Medcomp

Assessing impact of design on safety

Comparative infection risk analysis informed product design and safety monitoring.

5 Read the case study

Dexcom

Supporting expanded use

Linked outcomes showed slower kidney disease progression, strengthening value story for coverage.

5 Read the blog